<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/mltx" ></link>
<id>urn:uuid:f494f970-24b9-d0bb-badd-362b5ef398f3</id>
<updated>2026-06-18T13:22:18-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>MLTX: REICH KRISTIAN (O) Sold (AS) 150k Shares of MOONLAKE IMMUNOTHERAPEUTICS for $18.70-$19.43 on 6/15-6/17</title>
<link href="http://www.insiderinsights.com/company/mltx/moonlake-immunotherapeutics/id-6428954" ></link>
<id>urn:uuid:758008b8-24ed-70aa-97f1-b1da76426079</id>
<updated>2026-06-17T18:15:02-04:00</updated>
<summary type="html" ><![CDATA[MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Recent Price: $18.69. Mkt Cap:1.4B. 10D Vol: 768,340]]></summary>
</entry>
<entry>
<title>MLTX: BODENSTEDT MATTHIAS (CFO) Sold (AS) 13,653 Shares of MOONLAKE IMMUNOTHERAPEUTICS for $20.02 on 5/11</title>
<link href="http://www.insiderinsights.com/company/mltx/moonlake-immunotherapeutics/id-6401696" ></link>
<id>urn:uuid:86317359-8ef5-65c8-16bc-c651572f0810</id>
<updated>2026-05-13T16:10:12-04:00</updated>
<summary type="html" ><![CDATA[MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Recent Price: $18.69. Mkt Cap:1.4B. 10D Vol: 768,340]]></summary>
</entry>
<entry>
<title>MLTX: BODENSTEDT MATTHIAS (CFO) Sold (AS) 2,426 Shares of MOONLAKE IMMUNOTHERAPEUTICS for $19.56 on 4/14</title>
<link href="http://www.insiderinsights.com/company/mltx/moonlake-immunotherapeutics/id-6387043" ></link>
<id>urn:uuid:ed11d004-7358-3bb9-8c47-176d267ee258</id>
<updated>2026-04-16T16:10:22-04:00</updated>
<summary type="html" ><![CDATA[MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Recent Price: $18.69. Mkt Cap:1.4B. 10D Vol: 768,340]]></summary>
</entry>
<entry>
<title>MLTX: SANTOS DA SILVA JORGE (CEO,DIR) Sold (S) 150k Shares of MOONLAKE IMMUNOTHERAPEUTICS for $18.23 on 4/10-4/13</title>
<link href="http://www.insiderinsights.com/company/mltx/moonlake-immunotherapeutics/id-6386251" ></link>
<id>urn:uuid:86a8cff4-79ae-655f-6e14-04c93ddfd446</id>
<updated>2026-04-14T17:55:59-04:00</updated>
<summary type="html" ><![CDATA[MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Recent Price: $18.69. Mkt Cap:1.4B. 10D Vol: 768,340]]></summary>
</entry>
<entry>
<title>MLTX: BODENSTEDT MATTHIAS (CFO) Sold (AS) 87,795 Shares of MOONLAKE IMMUNOTHERAPEUTICS for $18.94-$19.51 on 4/9-4/10</title>
<link href="http://www.insiderinsights.com/company/mltx/moonlake-immunotherapeutics/id-6385033" ></link>
<id>urn:uuid:97561870-938e-f507-0c84-bc006ad841a6</id>
<updated>2026-04-10T18:06:45-04:00</updated>
<summary type="html" ><![CDATA[MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Recent Price: $18.69. Mkt Cap:1.4B. 10D Vol: 768,340]]></summary>
</entry>
<entry>
<title>MLTX: BVF PARTNERS L P IL (DIR,BO) Sold (JS*) 3.8mm Shares of MOONLAKE IMMUNOTHERAPEUTICS for $16.79 on 3/31</title>
<link href="http://www.insiderinsights.com/company/mltx/moonlake-immunotherapeutics/id-6379362" ></link>
<id>urn:uuid:5f3fe94e-f5d9-34d1-3ebe-be9f4413e8cb</id>
<updated>2026-04-02T16:48:05-04:00</updated>
<summary type="html" ><![CDATA[MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Recent Price: $18.69. Mkt Cap:1.4B. 10D Vol: 768,340]]></summary>
</entry>
<entry>
<title>MLTX: BODENSTEDT MATTHIAS (CFO) Acquired (JB) 354,296 Shares of MOONLAKE IMMUNOTHERAPEUTICS for $0.00 on 1/7</title>
<link href="http://www.insiderinsights.com/company/mltx/moonlake-immunotherapeutics/id-6306270" ></link>
<id>urn:uuid:583f288e-f25b-6ac1-45fe-7242cb0d0671</id>
<updated>2026-01-09T16:01:06-05:00</updated>
<summary type="html" ><![CDATA[MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Recent Price: $18.69. Mkt Cap:1.4B. 10D Vol: 768,340]]></summary>
</entry>
<entry>
<title>MLTX: BODENSTEDT MATTHIAS (CFO) Acquired (JB) 294,473 Shares of MOONLAKE IMMUNOTHERAPEUTICS for $0.00 on 12/19</title>
<link href="http://www.insiderinsights.com/company/mltx/moonlake-immunotherapeutics/id-6296474" ></link>
<id>urn:uuid:72ba5624-e6e9-d3ec-a35d-edb37cf77d02</id>
<updated>2025-12-22T16:02:32-05:00</updated>
<summary type="html" ><![CDATA[MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Recent Price: $18.69. Mkt Cap:1.4B. 10D Vol: 768,340]]></summary>
</entry>
<entry>
<title>MLTX: BODENSTEDT MATTHIAS (CFO) Disposed (JS) 294,473 Shares of MOONLAKE IMMUNOTHERAPEUTICS for $0.00 on 12/19</title>
<link href="http://www.insiderinsights.com/company/mltx/moonlake-immunotherapeutics/id-6296475" ></link>
<id>urn:uuid:8a9a30c7-2ec4-7f2f-d007-83c65beed8f3</id>
<updated>2025-12-22T16:02:32-05:00</updated>
<summary type="html" ><![CDATA[MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Recent Price: $18.69. Mkt Cap:1.4B. 10D Vol: 768,340]]></summary>
</entry>
<entry>
<title>MLTX: REICH KRISTIAN (O) Disposed (JS) 35,389 Shares of MOONLAKE IMMUNOTHERAPEUTICS for $0.00 on 12/19</title>
<link href="http://www.insiderinsights.com/company/mltx/moonlake-immunotherapeutics/id-6296480" ></link>
<id>urn:uuid:acd37c41-7c3c-e0e5-8a06-673e71e18508</id>
<updated>2025-12-22T16:02:01-05:00</updated>
<summary type="html" ><![CDATA[MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Recent Price: $18.69. Mkt Cap:1.4B. 10D Vol: 768,340]]></summary>
</entry>
</feed>